Twenty-five states are backing the federal government in litigation before two federal appeals courts over drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies.
A bipartisan group of state attorneys general filed friend of the court briefs this afternoon in support of the federal government in two sets of consolidated cases. The first set of cases, in the U.S. Court of Appeals for the District of Columbia, involves Novartis and United Therapeutics’ conditions on the 340B contract pharmacy program. The second, in the U.S. Third Circuit Court of Appeals in Philadelphia, involves Sanofi and Novo Nordisk’s policies.
Twenty-five states are backing the federal government in litigation before two federal appeals courts over drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
